TuneMe
AI-based App for Stress Regulation
Company Overview
Snapshot
Founded in November 2020, TuneMe operates with 1–10 employees. The company has secured funding across one round from one investor, eHealth Ventures. In August 2024, TuneMe received seed funding from eHealth Ventures.
Business overview
TuneMe develops virtual assistance software that integrates artificial intelligence and voice analysis to create personalized treatments. Its core technology focuses on innovative vibroacoustic neuro-stimulation designed to rebalance the autonomic nervous system. The company offers a multi-platform neurostimulation solution specifically targeting individuals experiencing PTSD and sleep difficulties, operating within the Digital Healthcare and Digital Therapeutics sectors and serving consumers and patients.
Company Intelligence Q&A
- What is TuneMe's primary focus?
- TuneMe specializes in AI-based applications for stress regulation, utilizing virtual assistance software that combines artificial intelligence and voice analysis to craft customized treatments.
- What technology does TuneMe use?
- TuneMe employs innovative vibroacoustic neuro-stimulation technology to rebalance the autonomic nervous system, offering a multi-platform neurostimulation solution.
- Which conditions does TuneMe's solution address?
- TuneMe's neurostimulation solution is specifically designed for individuals experiencing PTSD and sleep difficulties.
- When was TuneMe founded?
- TuneMe was founded in November 2020.